Medicon Ireland Ltd iXBRL


Relate AccountsProduction v2.7.2 v2.7.2 2022-01-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is the distribution of medical diagnostics, the supply of software and the wholesale supply of pharmaceutical products. 28 September 2023 0 0 NI058603 2022-12-31 NI058603 2021-12-31 NI058603 2020-12-31 NI058603 2022-01-01 2022-12-31 NI058603 2021-01-01 2021-12-31 NI058603 uk-bus:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 NI058603 uk-curr:PoundSterling 2022-01-01 2022-12-31 NI058603 uk-bus:SmallCompaniesRegimeForAccounts 2022-01-01 2022-12-31 NI058603 uk-bus:AbridgedAccounts 2022-01-01 2022-12-31 NI058603 uk-core:ShareCapital 2022-12-31 NI058603 uk-core:ShareCapital 2021-12-31 NI058603 uk-core:RetainedEarningsAccumulatedLosses 2022-12-31 NI058603 uk-core:RetainedEarningsAccumulatedLosses 2021-12-31 NI058603 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2022-12-31 NI058603 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2021-12-31 NI058603 uk-bus:FRS102 2022-01-01 2022-12-31 NI058603 uk-core:VehiclesPlantMachinery 2022-01-01 2022-12-31 NI058603 uk-core:PlantMachinery 2022-01-01 2022-12-31 NI058603 uk-core:FurnitureFittingsToolsEquipment 2022-01-01 2022-12-31 NI058603 uk-core:MotorVehicles 2022-01-01 2022-12-31 NI058603 2022-01-01 2022-12-31 NI058603 uk-bus:Director1 2022-01-01 2022-12-31 NI058603 uk-bus:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: NI058603
 
 
Medicon Ireland Ltd
 
Abridged Unaudited Financial Statements
 
for the financial year ended 31 December 2022
Medicon Ireland Ltd
Company Registration Number: NI058603
ABRIDGED STATEMENT OF FINANCIAL POSITION
as at 31 December 2022

2022 2021
Notes £ £
 
Non-Current Assets
Intangible assets 6 65,483 18,987
Property, plant and equipment 7 28,624 33,395
───────── ─────────
94,107 52,382
───────── ─────────
 
Current Assets
Stocks 27,251 43,227
Debtors 679,205 661,326
Cash and cash equivalents 828,146 614,541
───────── ─────────
1,534,602 1,319,094
───────── ─────────
Creditors: amounts falling due within one year (522,389) (553,236)
───────── ─────────
Net Current Assets 1,012,213 765,858
───────── ─────────
Total Assets less Current Liabilities 1,106,320 818,240
 
Creditors:
amounts falling due after more than one year - (34,027)
 
Provisions for liabilities (4,380) (5,156)
───────── ─────────
Net Assets 1,101,940 779,057
═════════ ═════════
 
Capital and Reserves
Called up share capital 2 2
Retained earnings 1,101,938 779,055
───────── ─────────
Equity attributable to owners of the company 1,101,940 779,057
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
           
The company has taken advantage of the exemption under section 444 not to file the Abridged Income Statement and Director's Report.
For the financial year ended 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges his responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 28 September 2023
           
           
________________________________          
Mr. Patrick I. McGowan          
Director          
           



Medicon Ireland Ltd
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 31 December 2022

   
1. General Information
 
Medicon Ireland Ltd is a company limited by shares incorporated in Northern Ireland. 16 Mount Charles, Belfast, BT7 1NZ is the registered office, 1a/1b, Carnbane Business Park, Newry BT35 6QH is the principal place of business of the company . The nature of the company's operations and its principal activities are set out in the Director's Report. The financial statements have been presented in Pound Sterling (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the year ended 31 December 2022 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets. The going concern basis assumes that the company will continue in operational existence for the foreseeable future, having adequate funds to meet its obligations as they fall due.
 
Turnover
Turnover represents the total invoice value, excluding value added tax, of sales made during the year and derives from the provision of goods falling within the company's ordinary activities.
 
Intangible assets
Intangible assets are valued at cost less accumulated amortisation.
 
Amortisation is calculated to write off the cost in equal annual instalments over their estimated useful life of 4 years.
 
Property, plant and equipment and depreciation
Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows:
 
  Short leasehold property - 2% Straight line
  Plant and machinery - 15% Straight line
  Fixtures, fittings and equipment - 25% Reducing balance
  Motor vehicles - 25% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Leasing and hire purchases
Property, plant and equipment held under leasing and Hire Purchases arrangements which transfer substantially all the risks and rewards of ownership to the company are capitalised and included in the Statement of Financial Position at their cost or valuation, less depreciation. The corresponding commitments are recorded as liabilities. Payments in respect of these obligations are treated as consisting of capital and interest elements, with interest charged to the Income Statement.
 
Leasing
Rentals payable under operating leases are dealt with in the Income Statement as incurred over the period of the rental agreement.
 
Stocks
Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition.  Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Borrowing costs
Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
 
Provisions
Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
 
Government grants
Capital grants received and receivable are treated as deferred income and amortised to the Income Statement annually over the useful economic life of the asset to which it relates. Revenue grants are credited to the Income Statement when received.
 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Statement of Financial Position date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Income Statement.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
   
3. Significant accounting judgements and key sources of estimation uncertainty
 
The preparation of financial statements requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. Actual results may differ from these estimates. No judgements were identified that would have a material impact on the companys’ financial statements.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects that period.
   
4. Going concern
 
We have continued to prepare the accounts on a going concern basis and deem this appropriate. We do not consider that a material uncertainty about our going concern status currently exists. In making this assessment we have considered the likely trading conditions for a period of 12 months from the date of the approval of these financial statements.
       
5. Employees
 
The average monthly number of employees, including director, during the financial year was 9, (2021 - 10).
       
6. Intangible assets
     
    Total
  £ £
Cost
At 1 January 2022 27,700 27,700
Additions 51,500 51,500
  ───────── ─────────
At 31 December 2022 79,200 79,200
  ───────── ─────────
Amortisation
At 1 January 2022 8,713 8,713
Charge for financial year 5,004 5,004
  ───────── ─────────
At 31 December 2022 13,717 13,717
  ───────── ─────────
Net book value
At 31 December 2022 65,483 65,483
  ═════════ ═════════
At 31 December 2021 18,987 18,987
  ═════════ ═════════
             
7. Property, plant and equipment
  Short Plant and Fixtures, Motor Total
  leasehold machinery fittings and vehicles  
  property   equipment    
  £ £ £ £ £
Cost or Valuation
At 1 January 2022 89,554 4,850 148,916 18,587 261,907
Additions - - 3,202 - 3,202
  ───────── ───────── ───────── ───────── ─────────
At 31 December 2022 89,554 4,850 152,118 18,587 265,109
  ───────── ───────── ───────── ───────── ─────────
Depreciation
At 1 January 2022 85,152 3,936 128,002 11,422 228,512
Charge for the financial year 676 183 5,323 1,791 7,973
  ───────── ───────── ───────── ───────── ─────────
At 31 December 2022 85,828 4,119 133,325 13,213 236,485
  ───────── ───────── ───────── ───────── ─────────
Net book value
At 31 December 2022 3,726 731 18,793 5,374 28,624
  ═════════ ═════════ ═════════ ═════════ ═════════
At 31 December 2021 4,402 914 20,914 7,165 33,395
  ═════════ ═════════ ═════════ ═════════ ═════════
   
8. Events After the End of the Reporting Period
 
The company is currently engaged in legal action against their main supplier regarding its supply contract. The outcome of this case and the potential financial effect is not yet known.